ORMPOramed Pharmaceuticals Inc.
3.920USD-0.25%Mkt Cap: 160.02M USDP/E: 1.50Last update: 2026-06-01

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, wh…

Indicators:|

Key Statistics

Company
Market Cap160.02M USD
Enterprise Value97.40M USD
Revenue (TTM)0 USD
Gross Profit13.00K USD
Net Income (TTM)64.05M USD
Revenue/Share0.0000 USD
Last Price3.920 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS68403P2039
Valuation
P/E (Trailing)1.50
P/E (Forward)-49.63
PEG
EV/EBITDA-6.89
EV/Revenue
P/SInfinity
P/B0.78
EPS (TTM)2.60
EPS (Forward)-0.08
52W Range
1.98064% of range5.010
52W High5.010 USD
52W Low1.980 USD
Profitability
Gross Margin0.65%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin3202.50%
ROE32.07%
ROA27.74%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-9.14M USD
CapEx (TTM)1.93M USD
FCF Margin
FCF Yield0.16%
Net Debt-65.08M USD
Net Debt/EBITDA4.61
Balance Sheet
Debt/Equity0.00
Current Ratio6.45
Quick Ratio6.28
Book Value/Sh5.086 USD
Cash/Share1.609 USD
Dividends
Fwd Div Rate0.2500 USD
Trail. Div Rate0.0000 USD
Div. Yield6.31%
5Y Avg Yield
Payout Ratio9.62%
Ex-Div DateJan 16, 2026
Pay DateJan 26, 2026
Splits
Last Split1:12
Split DateJan 23, 2013
Analyst Consensus
Rating
Target (Mean)6.250 USD
Target Range6.250 USD6.250 USD
# Analysts1
Ownership
Shares Out.40.93M
Float28.57M
Insiders17.83%
Institutions37.08%
Short Interest
Short Ratio3.8d
Short % Float1.84%
Short % Out.1.55%
Shares Short635.43K
Short (prev mo.)576.93K
Technical
SMA 503.862 (+1.5%)
SMA 2003.051 (+28.5%)
Beta1.26
S&P 52W Chg27.94%
Avg Vol (30d)184.59K
Avg Vol (10d)212.00K
Technical Indicators
RSI (14)44.7
MACD0.0355
MACD Signal0.1117
MACD Hist.-0.0762
BB Upper4.762 USD
BB Middle4.197 USD
BB Lower3.633 USD
BB Width26.90%
ATR (14)0.2490 USD
Vol Ratio (20d)0.50x